{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:22:37Z","timestamp":1790716957464,"version":"4.1.0"},"reference-count":131,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T00:00:00Z","timestamp":1644537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:p>\n                    Crohn\u2019s disease (CD) is an inflammatory bowel disease (IBD) with repeated remissions and relapses. As the disease progresses, fibrosis and narrowing of the intestine occur, leading to severe complications such as intestinal obstruction. Endoscopic balloon dilatation, surgical stricture plasty, and bowel resection have been performed to treat intestinal stenosis. The clinical issue is that some patients with CD have a recurrence of intestinal stenosis even after the medical treatments. On the other hand, there exist no established medical therapies to prevent stenosis. With the progressive intestinal inflammation, cytokines and growth factors, including transforming growth factor (TGF-\u03b2), stimulate intestinal myofibroblasts, contributing to fibrosis of the intestine, smooth muscle hypertrophy, and mesenteric fat hypertrophy. Therefore, chronically sustained inflammation has long been considered a cause of intestinal fibrosis and stenosis. Still, even after the advent of biologics and tighter control of inflammation, intestinal fibrosis\u2019s surgical rate has not necessarily decreased. It is essential to elucidate the mechanisms involved in intestinal fibrosis in CD from a molecular biological level to overcome clinical issues. Recently, much attention has been paid to several key molecules of intestinal fibrosis: peroxisome proliferator-activating receptor gamma (PPAR\u03b3), toll-like receptor 4 (TLR4), adherent-invasive\n                    <jats:italic>Escherichia coli<\/jats:italic>\n                    (AIEC), Th17 immune response, and plasminogen activator inhibitor 1 (PAI-1). As a major problem in the treatment of CD, the pathophysiology of patients with CD is not the same and varies depending on each patient. It is necessary to integrate these key molecules for a better understanding of the mechanism of intestinal inflammation and fibrosis.\n                  <\/jats:p>","DOI":"10.3389\/fphys.2022.845078","type":"journal-article","created":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T03:36:37Z","timestamp":1644550597000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":49,"title":["The Molecular Mechanisms of Intestinal Inflammation and Fibrosis in Crohn\u2019s Disease"],"prefix":"10.3389","volume":"13","author":[{"given":"Yuki","family":"Hayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Nakase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,11]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1007\/s10620-011-1644-8","article-title":"Perinodal adipose tissue and mesenteric lymph node activation during reactivated TNBS-colitis in rats","volume":"56","author":"Acedo","year":"2011","journal-title":"Dig. Dis. Sci."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1136\/gut.2005.081745","article-title":"Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease","volume":"55","author":"Adachi","year":"2006","journal-title":"Gut"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1177\/2042018815574229","article-title":"The effect of pioglitazone on weight, lipid profile and liver enzymes in type 2 diabetic patients","volume":"6","author":"Aghamohammadzadeh","year":"2015","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1148\/radiol.2423041600","article-title":"The fat halo sign","volume":"242","author":"Ahualli","year":"2007","journal-title":"Radiology"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nri1391","article-title":"Toll-like receptor signalling","volume":"4","author":"Akira","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.2337\/diabetes.49.8.1374","article-title":"Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity","volume":"49","author":"Alessi","year":"2000","journal-title":"Diabetes"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1177\/1076029611405034","article-title":"Continuous active state of coagulation system in patients with nonthrombotic inflammatory bowel disease","volume":"17","author":"Alkim","year":"2011","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1053\/j.gastro.2005.06.071","article-title":"Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts","volume":"129","author":"Andoh","year":"2005","journal-title":"Gastroenterology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1084\/jem.20070663","article-title":"Phenotypic and functional features of human Th17 cells","volume":"204","author":"Annunziato","year":"2007","journal-title":"J. Exp. Med."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/sj.gene.6364111","article-title":"NOD2\/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn\u2019s disease patients: evidence for genetic heterogeneity within Europe?","volume":"5","author":"Arnott","year":"2004","journal-title":"Genes Immun."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/ng.175","article-title":"Genome-wide association defines more than 30 distinct susceptibility loci for Crohn\u2019s disease","volume":"40","author":"Barrett","year":"2008","journal-title":"Nat. Genet."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000449079","article-title":"Pathogenesis of intestinal fibrosis in inflammatory bowel disease and perspectives for therapeutic implication","volume":"35","author":"Bettenworth","year":"2017","journal-title":"Dig. Dis."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1755-1536-6-13","article-title":"The role of interleukin 17 in Crohn\u2019s disease-associated intestinal fibrosis","volume":"6","author":"Biancheri","year":"2013","journal-title":"Fibrogenesis Tissue Repair"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"G827","DOI":"10.1152\/ajpgi.00513.2005","article-title":"IL-22 is increased in active Crohn\u2019s disease and promotes pro-inflammatory gene expression and intestinal epithelial cell migration","volume":"290","author":"Brand","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1097\/01.mib.0000168372.94907.d2","article-title":"The role of toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15\/NOD2 mutations in the susceptibility and phenotype of Crohn\u2019s disease","volume":"11","author":"Brand","year":"2005","journal-title":"Inflamm. Bowel Dis."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/cei.12381","article-title":"Toll-like receptor expression in crypt epithelial cells, putative stem cells and intestinal myofibroblasts isolated from controls and patients with inflammatory bowel disease","volume":"178","author":"Brown","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.4049\/jimmunol.168.3.1435","article-title":"Chlamydial heat shock protein 60 activates macrophages and endothelial cells through toll-like receptor 4 and MD2 in a MyD88-dependent pathway","volume":"168","author":"Bulut","year":"2002","journal-title":"J. Immunol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1126\/science.aam9949","article-title":"Microbiota-activated PPAR-\u03b3 signaling inhibits dysbiotic Enterobacteriaceae expansion","volume":"357","author":"Byndloss","year":"2017","journal-title":"Science"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"7010","DOI":"10.1128\/IAI.68.12.7010-7017.2000","article-title":"Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease","volume":"68","author":"Cario","year":"2000","journal-title":"Infect. Immun."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"925309","DOI":"10.1155\/2009\/925309","article-title":"Cross-talk between PPARs and the partners of RXR: a molecular perspective","volume":"2009","author":"Chan","year":"2009","journal-title":"PPAR Res."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"5055","DOI":"10.3390\/ijms20205055","article-title":"Exploration and development of PPAR modulators in health and disease: an update of clinical evidence","volume":"20","author":"Cheng","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e0126803","DOI":"10.1371\/journal.pone.0126803","article-title":"Association between TLR2 and TLR4 gene polymorphisms and the susceptibility to inflammatory bowel disease: a meta-analysis","volume":"10","author":"Cheng","year":"2015","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1007\/s10620-020-06227-0","article-title":"Strictures in Crohn\u2019s disease: from pathophysiology to treatment","volume":"65","author":"Crespi","year":"2020","journal-title":"Dig. Dis. Sci."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nri2800","article-title":"Innate IL-17-producing cells: the sentinels of the immune system","volume":"10","author":"Cua","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1053\/j.gastro.2004.04.061","article-title":"High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn\u2019s disease","volume":"127","author":"Darfeuille-Michaud","year":"2004","journal-title":"Gastroenterology"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"591561","DOI":"10.3389\/fphar.2020.591561","article-title":"Pioglitazone-mediated attenuation of experimental colitis relies on cleaving of annexin A1 released by macrophages","volume":"11","author":"da Rocha","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.3390\/microorganisms9091823","article-title":"Adherent-invasive and non-invasive Escherichia coli isolates differ in their effects on Caenorhabditis elegans\u2019 lifespan","volume":"9","author":"de Sousa Figueiredo","year":"2021","journal-title":"Microorganisms"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/s0016-5085(99)70552-4","article-title":"Inflammatory alterations in mesenteric adipose tissue in Crohn\u2019s disease","volume":"117","author":"Desreumaux","year":"1999","journal-title":"Gastroenterology"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1093\/jmcb\/mjaa036","article-title":"Development of a miniaturized 3D organoid culture platform for ultra-high-throughput screening","volume":"12","author":"Du","year":"2020","journal-title":"J. Mol. Cell Biol."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.cgh.2008.04.032","article-title":"Increased immune reactivity predicts aggressive complicating Crohn\u2019s disease in children","volume":"6","author":"Dubinsky","year":"2008","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/s0016-5085(03)00271-3","article-title":"Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis","volume":"124","author":"Dubuquoy","year":"2003","journal-title":"Gastroenterology"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1038\/s41467-021-22306-w","article-title":"High-throughput fitness screening and transcriptomics identify a role for a type IV secretion system in the pathogenesis of Crohn\u2019s disease-associated Escherichia coli","volume":"12","author":"Elhenawy","year":"2021","journal-title":"Nat. Commun."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"e00587","DOI":"10.1128\/IAI.00587-19","article-title":"Yersiniabactin-producing adherent\/invasive Escherichia coli promotes inflammation-associated fibrosis in Gnotobiotic Il10\u2212\/\u2212 mice","volume":"87","author":"Ellermann","year":"2019","journal-title":"Infect. Immun."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"G677","DOI":"10.1152\/ajpgi.00104.2011","article-title":"Themes in fibrosis and gastrointestinal inflammation","volume":"300","author":"Fiocchi","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1136\/gut.2003.030205","article-title":"Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn\u2019s disease and ulcerative colitis","volume":"53","author":"Franchimont","year":"2004","journal-title":"Gut"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"13780","DOI":"10.1073\/pnas.0706625104","article-title":"Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases","volume":"104","author":"Frank","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1111\/j.1572-0241.2005.00325.x","article-title":"Intestinal permeability and genetic determinants in patients, first-degree relatives, and controls in a high-incidence area of Crohn\u2019s disease in southern Italy","volume":"100","author":"Fries","year":"2005","journal-title":"Am. J. Gastroenterol."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1136\/gut.52.1.65","article-title":"Increased expression of interleukin 17 in inflammatory bowel disease","volume":"52","author":"Fujino","year":"2003","journal-title":"Gut"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nri2586","article-title":"Structure and signalling in the IL-17 receptor family","volume":"9","author":"Gaffen","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"16037","DOI":"10.1038\/nrdp.2016.37","article-title":"Disseminated intravascular coagulation","volume":"2","author":"Gando","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/j.1365-2559.2008.03130.x","article-title":"Submucosal fat deposition in a patient with Crohn\u2019s disease: the fat halo sign","volume":"53","author":"Giaslakiotis","year":"2008","journal-title":"Histopathology"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/ng1954","article-title":"A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1","volume":"39","author":"Hampe","year":"2007","journal-title":"Nat. Genet."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1053\/gast.2002.33662","article-title":"Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation","volume":"122","author":"Hausmann","year":"2002","journal-title":"Gastroenterology"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1136\/gutjnl-2013-305632","article-title":"Involvement of interleukin-17A-induced expression of heat shock protein 47 in intestinal fibrosis in Crohn\u2019s disease","volume":"63","author":"Honzawa","year":"2014","journal-title":"Gut"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"e581","DOI":"10.1002\/ams2.581","article-title":"Validating plasminogen activator inhibitor-1 as a poor prognostic factor in sepsis","volume":"7","author":"Hoshino","year":"2020","journal-title":"Acute Med. Surg."},{"key":"ref46","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.4049\/jimmunol.162.7.3749","article-title":"Cutting edge: toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product","volume":"162","author":"Hoshino","year":"1999","journal-title":"J. Immunol."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1136\/gutjnl-2011-301668","article-title":"Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn\u2019s disease: unexpected results of a randomised, double-blind placebo-controlled trial","volume":"61","author":"Hueber","year":"2012","journal-title":"Gut"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/35079107","article-title":"Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn\u2019s disease","volume":"411","author":"Hugot","year":"2001","journal-title":"Nature"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/ibd.21677","article-title":"Functional relevance of T helper 17 (Th17) cells and the IL-17 cytokine family in inflammatory bowel disease","volume":"18","author":"Hundorfean","year":"2012","journal-title":"Inflamm. Bowel Dis."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1155\/2010\/586092","article-title":"Mesalazine in inflammatory bowel disease: a trendy topic once again?","volume":"24","author":"Iacucci","year":"2010","journal-title":"Can. J. Gastroenterol."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/stem.1577","article-title":"Inhibition of plasminogen activator inhibitor type-1 activity enhances rapid and sustainable hematopoietic regeneration","volume":"32","author":"Ibrahim","year":"2014","journal-title":"Stem Cells"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"219","DOI":"10.5217\/ir.2019.00037","article-title":"Inhibition of plasminogen activator inhibitor-1 attenuates against intestinal fibrosis in mice","volume":"18","author":"Imai","year":"2020","journal-title":"Intest Res."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.dsx.2014.09.015","article-title":"PPAR gamma gene\u2014a review","volume":"9","author":"Janani","year":"2015","journal-title":"Diabetes Metab. Syndr."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"5233","DOI":"10.4049\/jimmunol.168.10.5233","article-title":"Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by toll-like receptor 4","volume":"168","author":"Johnson","year":"2002","journal-title":"J. Immunol."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1097\/00004728-198609000-00009","article-title":"Submucosal accumulation of fat in inflammatory bowel disease: CT\/pathologic correlation","volume":"10","author":"Jones","year":"1986","journal-title":"J. Comput. Assist. Tomogr."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"19867","DOI":"10.1038\/s41598-020-76880-y","article-title":"Toll-like receptor 4 regulates intestinal fibrosis via cytokine expression and epithelial-mesenchymal transition","volume":"10","author":"Jun","year":"2020","journal-title":"Sci. Rep."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"eaat0852","DOI":"10.1126\/scitranslmed.aat0852","article-title":"PAI-1 augments mucosal damage in colitis","volume":"11","author":"Kaiko","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/01.MIB.0000200345.38837.46","article-title":"Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease","volume":"12","author":"Karmiris","year":"2006","journal-title":"Inflamm. Bowel Dis."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1074\/jbc.275.4.2251","article-title":"Mouse toll-like receptor 4\u00b7MD-2 complex mediates lipopolysaccharide-mimetic signal transduction by taxol","volume":"275","author":"Kawasaki","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3389\/fimmu.2014.00461","article-title":"Toll-Like receptor Signaling pathways","volume":"5","author":"Kawasaki","year":"2014","journal-title":"Front. Immunol."},{"key":"ref61","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1053\/j.gastro.2005.02.009","article-title":"Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria","volume":"128","author":"Kim","year":"2005","journal-title":"Gastroenterology"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"e816856","DOI":"10.1155\/2015\/816856","article-title":"Review of the structural and dynamic mechanisms of PPAR\u03b3 partial agonism","volume":"2015","author":"Kroker","year":"2015","journal-title":"PPAR Res."},{"key":"ref63","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/80833","article-title":"Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus","volume":"1","author":"Kurt-Jones","year":"2000","journal-title":"Nat. Immunol."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/00054725-200108000-00008","article-title":"Altered response of intestinal mucosal fibroblasts to profibrogenic cytokines in inflammatory bowel disease","volume":"7","author":"Lawrance","year":"","journal-title":"Inflamm. Bowel Dis."},{"key":"ref65","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/00054725-200102000-00003","article-title":"Inflammation location, but not type, determines the increase in TGF-beta1 and IGF-1 expression and collagen deposition in IBD intestine","volume":"7","author":"Lawrance","year":"","journal-title":"Inflamm. Bowel Dis."},{"key":"ref66","doi-asserted-by":"publisher","first-page":"861238","DOI":"10.1155\/2010\/861238","article-title":"Virtual screening as a technique for PPAR modulator discovery","volume":"2010","author":"Lewis","year":"2010","journal-title":"PPAR Res."},{"key":"ref67","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1007\/s10620-019-05969-w","article-title":"Role of Interleukin-17 in pathogenesis of intestinal fibrosis in mice","volume":"65","author":"Li","year":"2020","journal-title":"Dig. Dis. Sci."},{"key":"ref68","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.immuni.2009.08.025","article-title":"Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis","volume":"31","author":"Lin","year":"2009","journal-title":"Immunity"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"9530","DOI":"10.1038\/srep09530","article-title":"Identification of a novel selective agonist of PPAR\u03b3 with no promotion of adipogenesis and less inhibition of osteoblastogenesis","volume":"5","author":"Liu","year":"2015","journal-title":"Sci. Rep."},{"key":"ref70","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1038\/s12276-021-00641-8","article-title":"Organoids in image-based phenotypic chemical screens","volume":"53","author":"Lukonin","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"ref71","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/0092-8674(95)90199-x","article-title":"The nuclear receptor superfamily: the second decade","volume":"83","author":"Mangelsdorf","year":"1995","journal-title":"Cell"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"G311","DOI":"10.1152\/ajpgi.00038.2012","article-title":"MyD88 signaling promotes both mucosal homeostatic and fibrotic responses during salmonella-induced colitis","volume":"303","author":"M\u00e5nsson","year":"2012","journal-title":"Am. J. Physiol. Gastrointest."},{"key":"ref73","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.ejmech.2019.01.067","article-title":"Role of PPAR receptor in different diseases and their ligands: physiological importance and clinical implications","volume":"166","author":"Mirza","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref74","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1136\/gut.2006.093187","article-title":"Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21","volume":"55","author":"Monteleone","year":"2006","journal-title":"Gut"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1053\/j.gastro.2004.12.042","article-title":"Interleukin-21 enhances T-helper cell type I signaling and interferon-gamma production in Crohn\u2019s disease","volume":"128","author":"Monteleone","year":"2005","journal-title":"Gastroenterology"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"653655","DOI":"10.3389\/fcvm.2021.653655","article-title":"A serpin With a finger in many PAIs: PAI-1\u2019s central function in Thromboinflammation and cardiovascular disease","volume":"8","author":"Morrow","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"ref77","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S1359-6101(03)00002-9","article-title":"Interleukin-17 family and IL-17 receptors","volume":"14","author":"Moseley","year":"2003","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref78","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1517\/13543784.2015.1035432","article-title":"Inflammatory bowel disease therapies discontinued between 2009 and 2014","volume":"24","author":"Mozaffari","year":"2015","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1097\/00004728-199505000-00010","article-title":"\u201cAcute\u201d fat deposition in bowel wall submucosa: CT appearance","volume":"19","author":"Muldowney","year":"1995","journal-title":"J. Comput. Assist. Tomogr."},{"key":"ref80","doi-asserted-by":"publisher","first-page":"565.e4","DOI":"10.1053\/j.gastro.2014.12.001","article-title":"Inhibition of plasmin protects against colitis in mice by suppressing matrix metalloproteinase 9-mediated cytokine release from myeloid cells","volume":"148","author":"Munakata","year":"2015","journal-title":"Gastroenterology"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"10229","DOI":"10.1074\/jbc.M100099200","article-title":"The extra domain A of fibronectin activates toll-like receptor 4","volume":"276","author":"Okamura","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref82","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1097\/01.mib.0000161305.81198.0f","article-title":"Association between toll-like receptor 4 and inflammatory bowel disease","volume":"11","author":"Oostenbrug","year":"2005","journal-title":"Inflamm. Bowel Dis."},{"key":"ref83","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1248\/cpb.59.1233","article-title":"A novel series of (S)-2,7-Substituted-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids: peroxisome proliferator-activated receptor \u03b1\/\u03b3 dual agonists with protein-tyrosine phosphatase 1B inhibitory activity","volume":"59","author":"Otake","year":"2011","journal-title":"Chem. Pharm. Bull."},{"key":"ref84","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1016\/S0016-5085(03)00403-7","article-title":"Intestinal myofibroblasts in innate immune responses of the intestine","volume":"124","author":"Otte","year":"2003","journal-title":"Gastroenterology"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/ng2061","article-title":"Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn\u2019s disease susceptibility","volume":"39","author":"Parkes","year":"2007","journal-title":"Nat. Genet."},{"key":"ref86","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.micinf.2011.04.008","article-title":"Yersiniabactin iron uptake: mechanisms and role in Yersinia pestis pathogenesis","volume":"13","author":"Perry","year":"2011","journal-title":"Microbes Infect."},{"key":"ref87","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrc3214","article-title":"The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention","volume":"12","author":"Peters","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nm1743","article-title":"Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes salmonella dissemination from the gut","volume":"14","author":"Raffatellu","year":"2008","journal-title":"Nat. Med."},{"key":"ref89","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.3390\/biom11091301","article-title":"Repurposing small molecules to target PPAR-\u03b3 as new therapies for peripheral nerve injuries","volume":"11","author":"Rayner","year":"2021","journal-title":"Biomol. Ther."},{"key":"ref90","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1161\/01.CIR.0000161823.55935.BE","article-title":"Inflammatory cytokines interleukin-6 and oncostatin m induce plasminogen activator inhibitor-1 in human adipose tissue","volume":"111","author":"Rega","year":"2005","journal-title":"Circulation"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1136\/gut.2006.090456","article-title":"Wound healing and fibrosis in intestinal disease","volume":"56","author":"Rieder","year":"2007","journal-title":"Gut"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"340.e6","DOI":"10.1053\/j.gastro.2016.09.047","article-title":"Mechanisms, management, and treatment of fibrosis in patients with inflammatory bowel diseases","volume":"152","author":"Rieder","year":"2017","journal-title":"Gastroenterology"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1136\/gutjnl-2012-304353","article-title":"Crohn\u2019s disease complicated by strictures: a systematic review","volume":"62","author":"Rieder","year":"2013","journal-title":"Gut"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41576-018-0051-9","article-title":"Progress and potential in organoid research","volume":"19","author":"Rossi","year":"2018","journal-title":"Nat. Rev. Genet."},{"key":"ref95","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1084\/jem.20041948","article-title":"Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma","volume":"201","author":"Rousseaux","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref96","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1084\/jem.20110462","article-title":"The Th17 immune response is controlled by the Rel\u2013ROR\u03b3\u2013ROR\u03b3T transcriptional axis","volume":"208","author":"Ruan","year":"2011","journal-title":"J. Exp. Med."},{"key":"ref97","doi-asserted-by":"publisher","first-page":"6902","DOI":"10.1073\/pnas.96.12.6902","article-title":"Tumor necrosis factor alpha is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1","volume":"96","author":"Samad","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref98","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1160\/TH08-05-0273","article-title":"Integration of non-SMAD and SMAD signaling in TGF-\u03b21-induced plasminogen activator inhibitor type-1 gene expression in vascular smooth muscle cells","volume":"100","author":"Samarakoon","year":"2008","journal-title":"Thromb. Haemost."},{"key":"ref99","doi-asserted-by":"publisher","first-page":"11","DOI":"10.14196\/mjiri.32.11","article-title":"Investigation of adherent-invasive E. coli in patients with Crohn\u2019s disease","volume":"32","author":"Sarabi Asiabar","year":"2018","journal-title":"Med. J. Islam Repub. Iran"},{"key":"ref100","first-page":"80","article-title":"Risk factors for recurrence of stenosis in Crohn\u2019s disease","volume":"74","author":"Scarpa","year":"2003","journal-title":"Acta Biomed."},{"key":"ref101","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1136\/gut.2004.061531","article-title":"Creeping fat in Crohn\u2019s disease: travelling in a creeper lane of research?","volume":"54","author":"Sch\u00e4ffler","year":"2005","journal-title":"Gut"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/bjs.1800790934","article-title":"Fat-wrapping in Crohn\u2019s disease: pathological basis and relevance to surgical practice","volume":"79","author":"Sheehan","year":"1992","journal-title":"Br. J. Surg."},{"key":"ref103","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.3390\/ijms22052721","article-title":"A narrative review on plasminogen activator Inhibitor-1 and its (Patho)physiological role: to target or not to target?","volume":"22","author":"Sillen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"ref104","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1038\/ncomms2957","article-title":"Persistent infection with Crohn\u2019s disease-associated adherent-invasive Escherichia coli leads to chronic inflammation and intestinal fibrosis","volume":"4","author":"Small","year":"2013","journal-title":"Nat. Commun."},{"key":"ref105","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.4049\/jimmunol.167.5.2887","article-title":"Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4","volume":"167","author":"Smiley","year":"2001","journal-title":"J. Immunol."},{"key":"ref106","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1136\/gutjnl-2019-318719","article-title":"Prominence of ileal mucosa-associated microbiota to predict postoperative endoscopic recurrence in Crohn\u2019s disease","volume":"69","author":"Sokol","year":"2020","journal-title":"Gut"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.3748\/wjg.v18.i28.3635","article-title":"Cellular and molecular mechanisms of intestinal fibrosis","volume":"18","author":"Speca","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"ref108","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/MIB.0000000000000618","article-title":"Novel PPAR\u03b3 modulator GED-0507-34 Levo ameliorates inflammation-driven intestinal fibrosis","volume":"22","author":"Speca","year":"2016","journal-title":"Inflamm. Bowel Dis."},{"key":"ref109","doi-asserted-by":"publisher","first-page":"E149","DOI":"10.3390\/biomedicines8060149","article-title":"CD40 receptor knockout protects against microcystin-LR (MC-LR) prolongation and exacerbation of dextran sulfate sodium (DSS)-induced colitis","volume":"8","author":"Su","year":"2020","journal-title":"Biomedicine"},{"key":"ref110","first-page":"jjab159","article-title":"The complex relationship between microbiota, immune response and creeping fat in Crohn\u2019s disease","volume-title":"J. Crohns Colitis","author":"Suau","year":"2021"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1084\/jem.20060285","article-title":"A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis","volume":"203","author":"Sutton","year":"2006","journal-title":"J. Exp. Med."},{"key":"ref112","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1101\/gad.8.10.1224","article-title":"mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer","volume":"8","author":"Tontonoz","year":"","journal-title":"Genes Dev."},{"key":"ref113","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/0092-8674(94)90006-x","article-title":"Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor","volume":"79","author":"Tontonoz","year":"","journal-title":"Cell"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"15107","DOI":"10.1074\/jbc.M111204200","article-title":"HSP70 as endogenous stimulus of the toll\/interleukin-1 receptor signal pathway","volume":"277","author":"Vabulas","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref115","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/00054725-200401000-00009","article-title":"Medical therapy for Crohn\u2019s disease strictures","volume":"10","author":"Van Assche","year":"2004","journal-title":"Inflamm. Bowel Dis."},{"key":"ref116","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1007\/s00018-008-8064-8","article-title":"TLR-4, IL-1R and TNF-R signaling to NF-\u03baB: variations on a common theme","volume":"65","author":"Verstrepen","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"ref117","doi-asserted-by":"publisher","first-page":"G601","DOI":"10.1152\/ajpgi.00022.2008","article-title":"Lipopolysaccharide activates innate immune responses in murine intestinal myofibroblasts through multiple signaling pathways","volume":"296","author":"Walton","year":"2009","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref118","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/ni.2479","article-title":"The psoriasis-associated D10N variant of the adaptor Act1 with impaired regulation by the molecular chaperone hsp90","volume":"14","author":"Wang","year":"2013","journal-title":"Nat. Immunol."},{"key":"ref119","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.coi.2009.12.005","article-title":"TLR signalling regulated antigen presentation in dendritic cells","volume":"22","author":"Watts","year":"2010","journal-title":"Curr. Opin. Immunol."},{"key":"ref120","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1172\/JCI19246","article-title":"Obesity is associated with macrophage accumulation in adipose tissue","volume":"112","author":"Weisberg","year":"2003","journal-title":"J. Clin. Invest."},{"key":"ref121","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1210\/me.2013-1427","article-title":"Minireview: challenges and opportunities in development of PPAR agonists","volume":"28","author":"Wright","year":"2014","journal-title":"Mol. Endocrinol."},{"key":"ref122","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1172\/JCI31487","article-title":"Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases","volume":"117","author":"Wynn","year":"2007","journal-title":"J. Clin. Invest."},{"key":"ref123","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1182\/blood-2017-02-767384","article-title":"TGF-\u03b2\u2013induced intracellular PAI-1 is responsible for retaining hematopoietic stem cells in the niche","volume":"130","author":"Yahata","year":"2017","journal-title":"Blood"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.cardiores.2004.11.013","article-title":"Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly","volume":"66","author":"Yamamoto","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"ref125","doi-asserted-by":"publisher","first-page":"e932530","DOI":"10.1155\/2014\/932530","article-title":"Peroxisome proliferator-activated receptors family is involved in the response to treatment and mild clinical course in patients with ulcerative colitis","volume":"2014","author":"Yamamoto-Furusho","year":"2014","journal-title":"Dis. Markers"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1084\/jem.194.4.519","article-title":"Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense","volume":"194","author":"Ye","year":"2001","journal-title":"J. Exp. Med."},{"key":"ref127","doi-asserted-by":"publisher","first-page":"32696","DOI":"10.1155\/2007\/32696","article-title":"Selective modulators of PPAR-\u03b3 activity: molecular aspects related to obesity and side-effects","volume":"2007","author":"Zhang","year":"2007","journal-title":"PPAR Res."},{"key":"ref128","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1007\/s10620-018-5234-x","article-title":"IL-17A promotes initiation and development of intestinal fibrosis through EMT","volume":"63","author":"Zhang","year":"2018","journal-title":"Dig. Dis. Sci."},{"key":"ref129","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41385-020-0259-9","article-title":"Selective deletion of MyD88 signaling in \u03b1-SMA positive cells ameliorates experimental intestinal fibrosis via post-transcriptional regulation","volume":"13","author":"Zhao","year":"2020","journal-title":"Mucosal Immunol."},{"key":"ref130","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/j.1751-2980.2012.00607.x","article-title":"Dynamic progress of 2,4,6-trinitrobenzene sulfonic acid induced chronic colitis and fibrosis in rat model","volume":"13","author":"Zhu","year":"2012","journal-title":"J. Dig. Dis."},{"key":"ref131","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1471-230X-9-62","article-title":"Tolllike receptor 4 (TLR4) polymorphisms in Tunisian patients with Crohn\u2019s disease: genotype-phenotype correlation","volume":"9","author":"Zouiten-Mekki","year":"2009","journal-title":"BMC Gastroenterol."}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2022.845078\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T11:18:17Z","timestamp":1674731897000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2022.845078\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,11]]},"references-count":131,"alternative-id":["10.3389\/fphys.2022.845078"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2022.845078","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,11]]},"article-number":"845078"}}